| pubmed-article:15131558 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15131558 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15131558 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:15131558 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:15131558 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
| pubmed-article:15131558 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:15131558 | lifeskim:mentions | umls-concept:C0289313 | lld:lifeskim |
| pubmed-article:15131558 | lifeskim:mentions | umls-concept:C0333186 | lld:lifeskim |
| pubmed-article:15131558 | lifeskim:mentions | umls-concept:C2348535 | lld:lifeskim |
| pubmed-article:15131558 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:15131558 | pubmed:dateCreated | 2004-5-7 | lld:pubmed |
| pubmed-article:15131558 | pubmed:abstractText | Thiazolidinediones have been shown to have an antiproliferative vascular effect in experimental models. We sought to study the effect of rosiglitazone on in-stent restenosis in patients with established type 2 diabetes. | lld:pubmed |
| pubmed-article:15131558 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15131558 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15131558 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15131558 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15131558 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15131558 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15131558 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15131558 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15131558 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15131558 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15131558 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15131558 | pubmed:month | May | lld:pubmed |
| pubmed-article:15131558 | pubmed:issn | 1097-6744 | lld:pubmed |
| pubmed-article:15131558 | pubmed:author | pubmed-author:WaxmanSergioS | lld:pubmed |
| pubmed-article:15131558 | pubmed:author | pubmed-author:UretskyBarry... | lld:pubmed |
| pubmed-article:15131558 | pubmed:author | pubmed-author:FitzgeraldPet... | lld:pubmed |
| pubmed-article:15131558 | pubmed:author | pubmed-author:OsmanAbdulfat... | lld:pubmed |
| pubmed-article:15131558 | pubmed:author | pubmed-author:OteroJavierJ | lld:pubmed |
| pubmed-article:15131558 | pubmed:author | pubmed-author:BrizolaraAlbe... | lld:pubmed |
| pubmed-article:15131558 | pubmed:author | pubmed-author:StoufferGeorg... | lld:pubmed |
| pubmed-article:15131558 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15131558 | pubmed:volume | 147 | lld:pubmed |
| pubmed-article:15131558 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15131558 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15131558 | pubmed:pagination | e23 | lld:pubmed |
| pubmed-article:15131558 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:meshHeading | pubmed-meshheading:15131558... | lld:pubmed |
| pubmed-article:15131558 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15131558 | pubmed:articleTitle | Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes. | lld:pubmed |
| pubmed-article:15131558 | pubmed:affiliation | Division of Cardiology, University of Texas Medical Branch, Galveston, Texas, USA. | lld:pubmed |
| pubmed-article:15131558 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15131558 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15131558 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:15131558 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15131558 | lld:pubmed |
